On this day in 2020, the Moderna COVID-19 vaccine entered phase 1 trials, making it the first COVID vaccine to do so. This came less than a week after the World Health Organisation declared COVID-19 a global pandemic. How was it possible for this to happen so quickly? The third part of the #ChemVsCOVID series, produced with the Royal Society of Chemistry, gives a brief overview of the prior work and what the phase 1 trials looked at.
RNA vaccines produced by Pfizer/BioNTech and Moderna were amongst the first vaccines approved for emergency use in fighting the COVID-19 pandemic. The latest edition of Periodic Graphics in Chemical & Engineering News looks at how these vaccines are made. Click through to the C&EN site to view the full graphic.
By now, we’re all familiar with the image of coronavirus. The spikey blob peppers news websites, looms behind reporters during bulletins and frequently punctuates your Twitter doom-scrolling. More recently, the news accompanying this image has taken a positive turn, with promising results from the COVID-19 vaccine trials. It’s the iconic spikes of the coronavirus spikey blob that are a key part of how these vaccines work.